• 2000

Company Description

InDex Pharmaceuticals is a biopharmaceutical company developing DIMS drugs to treat inflammatory diseases and cancer.

InDex Pharmaceuticals AB is a clinical stage biopharmaceutical company building a leading immunotherapy franchise based on its TLR platform (toll-like receptors). It discovers and develops DIMS drugs (DNA-based immunomodulatory sequence) to treat diseases within a variety of therapeutic areas, including inflammation and cancer.